After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...

BD has become the subject of a lawsuit from Tela Bio, with the rival maker of surgical mesh implants saying the major medtech wielded its sector dominance to push competing products out of the hernia ...

Q2 fiscal 2026 Management view "We delivered a solid second quarter with revenue, adjusted margins and adjusted EPS all ahead of our expectations" (President, CEO & Chairman Thomas Polen), adding, ...

The scientific-instrument company Waters will deepen its biological sciences footprint by merging with the biosciences and diagnostic solution business of Becton, Dickinson (BD). The companies value ...